Low-dose versus high-dose dexamethasone for hospitalized patients with COVID-19 pneumonia: A randomized clinical trial

BACKGROUND: Dexamethasone 6 mg daily for 10 days is the recommended treatment for patients with severe or critical coronavirus disease 2019 (COVID-19). The evidence on the benefit of high-dose dexamethasone is limited. The goal of this study was to assess the effects of 6 mg daily vs. 20 mg daily of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huimin, Daouk, Salim, Kebbe, Jad, Chaudry, Fawad, Harper, Jarrod, Brown, Brent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529091/
https://www.ncbi.nlm.nih.gov/pubmed/36190994
http://dx.doi.org/10.1371/journal.pone.0275217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529091/
https://www.ncbi.nlm.nih.gov/pubmed/36190994
http://dx.doi.org/10.1371/journal.pone.0275217

Ejemplares similares